Back to Search Start Over

Alanine Mutants of the Interface Residues of Human Thymidylate Synthase Decode Key Features of the Binding Mode of Allosteric Anticancer Peptides

Authors :
Janet Finer-Moore
Giambattista Guaitoli
Maria Paola Costi
Anna Tochowicz
Matteo Trande
Robert M. Stroud
Puneet Saxena
Matteo Santucci
Source :
Tochowicz, A; Santucci, M; Saxena, P; Guaitoli, G; Trande, M; Finer-Moore, J; et al.(2015). Alanine mutants of the interface residues of human thymidylate synthase decode key features of the binding mode of allosteric anticancer peptides. J Med Chem, 58(2). UC Office of the President: Multicampus Research Programs and Initiatives (MRPI); a funding opportunity through UC Research Initiatives (UCRI). Retrieved from: http://www.escholarship.org/uc/item/8k4226b6, J Med Chem
Publication Year :
2014
Publisher :
American Chemical Society (ACS), 2014.

Abstract

Allosteric peptide inhibitors of thymidylate synthase (hTS) bind to the dimer interface and stabilize the inactive form of the protein. Four interface residues were mutated to alanine, and interaction studies were employed to decode the key role of these residues in the peptide molecular recognition. This led to the identification of three crucial interface residues F59, L198, and Y202 that impart activity to the peptide inhibitors and suggest the binding area for further inhibitor design.

Details

ISSN :
15204804 and 00222623
Volume :
58
Database :
OpenAIRE
Journal :
Journal of Medicinal Chemistry
Accession number :
edsair.doi.dedup.....71a8dd65a1cf9be777071f4979a95b36
Full Text :
https://doi.org/10.1021/jm5011176